Brazil's CADE fines firms over three-decade global pharma cartel

By Henrique Santiago ( November 4, 2026, 20:37 GMT | Insight) -- The Superintendence of Brazil’s competition authority sanctioned Alchem International, Alkaloids of India, Alkaloids of Australia and Vital Laboratories, as well as three individuals, for participating in a cartel involving the production and sale of an ingredient used to manufacture Buscopan, whose effects were felt in the South American country. The fines totaled more than 17 million reais (over $3 million).A five-year probe resulted in the liability of pharma companies Alchem International, Alkaloids of India, Alkaloids of Australia and Vital Laboratories. Three individuals, Christopher Kenneth Joyce, Rajiv Bajaj and Stefan Bertram, were also held accountable....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login